Myfortic
These highlights do not include all the information needed to use MYFORTIC safely and effectively. See full prescribing information for MYFORTIC. MYFORTIC (mycophenolic acid) delayed-release tablets, for oral use Initial U.S. Approval: 2004
eed26501-890d-4ff6-88e7-6dbea4726e53
HUMAN PRESCRIPTION DRUG LABEL
Aug 8, 2023
Novartis Pharmaceuticals Corporation
DUNS: 002147023
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
mycophenolic acid
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
mycophenolic acid
Product Details
FDA regulatory identification and product classification information